Had a shingrix 2019 and last in 2024.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Had a shingrix 2019). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Had a shingrix 2019 and last in 2024.). The outcome of the drug dose administration interval too long was unknown. Additional Information: GSK Receipt Date: 07-JAN-2025 The reporter had a Shingrix 2019 and last in 2024. The reporter asked does he/she still need a third shot. The patient received second dose of Shingrix longer than the recommended interval which led to lengthening of vaccination schedule.